Javascript must be enabled to continue!
Rare disease patients’ participation in research. A Rare Barometer survey
View through CrossRef
This report presents the in-depth results of the Rare Barometer survey on rare disease patients’ participation in research. Over 3000 people living with a rare disease and their family members responded to this global Rare Barometer survey. - More than one third (37%) of rare disease patients surveyed declare they have already participated in a research study. - Among those who participated in research, 18% specified they have participated in research to develop treatments and therapies. Participation in research to develop treatments and therapies varies significantly across patients’ countries and disease area. Results also show a gender gap in inclusion in clinical studies: more men (21%) than woman (16%) have participated in research to develop treatments. - The main motivations that lead rare disease patients to participate in research are first the fact that they want to help science and the community and then to receive new treatment options. - A quality relationship with researchers is by far the main factor contributing to satisfaction with the participation in a research project. Having the possibility to be closely and regularly followed by a research team is also reported as one of the positive aspect of patients’ participation. - Regarding rare disease patients’ perspectives on rare disease research, among rare disease research areas, therapeutic research is considered as the highest priority. In parallel, the lack of public funding is identified as the main obstacle to rare disease research.
Title: Rare disease patients’ participation in research. A Rare Barometer survey
Description:
This report presents the in-depth results of the Rare Barometer survey on rare disease patients’ participation in research.
Over 3000 people living with a rare disease and their family members responded to this global Rare Barometer survey.
- More than one third (37%) of rare disease patients surveyed declare they have already participated in a research study.
- Among those who participated in research, 18% specified they have participated in research to develop treatments and therapies.
Participation in research to develop treatments and therapies varies significantly across patients’ countries and disease area.
Results also show a gender gap in inclusion in clinical studies: more men (21%) than woman (16%) have participated in research to develop treatments.
- The main motivations that lead rare disease patients to participate in research are first the fact that they want to help science and the community and then to receive new treatment options.
- A quality relationship with researchers is by far the main factor contributing to satisfaction with the participation in a research project.
Having the possibility to be closely and regularly followed by a research team is also reported as one of the positive aspect of patients’ participation.
- Regarding rare disease patients’ perspectives on rare disease research, among rare disease research areas, therapeutic research is considered as the highest priority.
In parallel, the lack of public funding is identified as the main obstacle to rare disease research.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract
Introduction
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...
Determinants of citizens’ electronic participation: insights from India
Determinants of citizens’ electronic participation: insights from India
Purpose– The purpose of the present paper is to attempt to examine the determinants of citizens’ electronic participation with respect to the communication aspects. To accomplish t...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
An Assessment of the performance of the National Health Research System in Mauritius to accelerate progress towards Universal Health Coverage
An Assessment of the performance of the National Health Research System in Mauritius to accelerate progress towards Universal Health Coverage
Abstract
Background: The goal of universal health coverage (UHC) is that every individual has access to quality health services without running the consequences of financia...
Management of Lower Limb Varicose Veins Using Endovenous Laser Ablation, Micro-Phlebectomy, and Sclerotherapy Using Multimodal Analgesia
Management of Lower Limb Varicose Veins Using Endovenous Laser Ablation, Micro-Phlebectomy, and Sclerotherapy Using Multimodal Analgesia
Abstract
Introduction
Previously, the conventional surgical procedure of high-ligation and saphenous stripping was commonly used to treat varicose veins (VVs). However, contemporar...

